Brazil Approves Novo Nordisk’s Wegovy Obesity Pill
The approval opens Brazil’s obesity market to a daily oral GLP-1 treatment after clinical trials showed…
N1VO34 is a BDR (Brazilian Depositary Receipt) traded on B3 that represents shares of Novo Nordisk, a company listed outside Brazil. BDRs let investors in Brazil buy foreign stocks in reais.
The approval opens Brazil’s obesity market to a daily oral GLP-1 treatment after clinical trials showed…
With semaglutide exclusivity ending March 20 and at least 20 generic applications filed, the Danish drugmaker…
German Chancellor Friedrich Merz pledged to press ahead with his economic overhaul despite a historic election…
Glencore Plc said profits jumped as a trading boom and surging copper prices lifted the commodities…
Semavy, marketed under the Mantecorp brand, is expected to reach pharmacies within two months as Brazil…
The United States announced sweeping 10% tariffs on major trading partners — including China, the European…
U.S. stocks found significant tailwinds yesterday following an early announcement that Meta Platforms Inc. plans to…
Global markets are bracing for increased volatility as Chinese regulators have reportedly advised domestic institutions to…
Global markets presented a mixed picture on Thursday, with robust earnings from UBS Group AG overshadowed…
Market data by TradingView. Informational only — not investment advice.